Total Payments
$6,260
2024 Payments
$1,716
Companies
34
Transactions
338
Medicare Patients
5,541
Medicare Billing
$371,396
Payment Breakdown by Category
Food & Beverage$6,242 (99.7%)
Education$18.51 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,242 | 336 | 99.7% |
| Education | $18.51 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,110 | 83 | $0 (2024) |
| Novo Nordisk Inc | $703.90 | 48 | $0 (2024) |
| Dexcom, Inc. | $384.22 | 24 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $346.44 | 14 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $325.45 | 19 | $0 (2024) |
| Radius Health, Inc. | $305.47 | 13 | $0 (2024) |
| Insulet Corporation | $303.70 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $299.91 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $268.53 | 14 | $0 (2024) |
| Corcept Therapeutics | $239.50 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,716 | 91 | Lilly USA, LLC ($250.91) |
| 2023 | $2,001 | 98 | Lilly USA, LLC ($317.45) |
| 2022 | $1,095 | 64 | Lilly USA, LLC ($349.39) |
| 2021 | $1,449 | 85 | Novo Nordisk Inc ($285.90) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/07/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: Insulin Pump | ||||||
| 11/07/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ENDOCRINE AGENT | ||||||
| 11/06/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $17.58 | General |
| 10/31/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/22/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/26/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Obesity | ||||||
| 09/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Endocrinology | ||||||
| 09/10/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.74 | General |
| 09/03/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Durable Pump | ||||||
| 08/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Cardio-renal | ||||||
| 08/20/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,415 | 3,410 | $274,034 | $105,069 |
| 2022 | 8 | 1,393 | 2,605 | $187,329 | $87,533 |
| 2021 | 8 | 1,438 | 2,744 | $212,325 | $96,574 |
| 2020 | 11 | 1,295 | 2,627 | $203,552 | $82,220 |
Total Patients
5,541
Total Services
11,386
Medicare Billing
$371,396
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 400 | 1,062 | $204,966 | $79,727 | 38.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 159 | 381 | $28,575 | $8,409 | 29.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 363 | 808 | $20,200 | $7,600 | 37.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 403 | 1,069 | $10,690 | $3,388 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 21 | $5,439 | $2,491 | 45.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $2,904 | $2,370 | 81.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 36 | $1,260 | $1,085 | 86.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 393 | 811 | $131,905 | $66,162 | 50.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 363 | 644 | $16,100 | $6,083 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $11,609 | $4,930 | 42.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 114 | 194 | $14,550 | $4,455 | 30.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 413 | 845 | $8,450 | $2,689 | 31.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $1,936 | $1,439 | 74.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 17 | $1,904 | $1,042 | 54.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $875.00 | $733.50 | 83.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 382 | 900 | $144,000 | $71,121 | 49.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 331 | 615 | $15,375 | $5,955 | 38.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 57 | 57 | $13,965 | $5,767 | 41.3% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 94 | 178 | $13,350 | $4,104 | 30.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 90 | $10,080 | $4,091 | 40.6% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2021 | 22 | 22 | $6,160 | $2,606 | 42.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 378 | 767 | $7,670 | $2,483 | 32.4% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 100 | 115 | $1,725 | $448.02 | 26.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 365 | 909 | $145,440 | $59,130 | 40.7% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 318 | 606 | $15,150 | $5,847 | 38.6% |
About Rebecca Pace, NP
Rebecca Pace, NP is a Family healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2017. The National Provider Identifier (NPI) number assigned to this provider is 1427596568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rebecca Pace, NP has received a total of $6,260 in payments from pharmaceutical and medical device companies, with $1,716 received in 2024. These payments were reported across 338 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,242).
As a Medicare-enrolled provider, Pace has provided services to 5,541 Medicare beneficiaries, totaling 11,386 services with total Medicare billing of $371,396. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Chesapeake, VA
- Active Since 02/09/2017
- Last Updated 11/02/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1427596568
Products in Payments
- JARDIANCE (Drug) $445.70
- Ozempic (Drug) $406.62
- Dexcom G6 Transmitter (Medical Supply) $353.63
- Kerendia (Drug) $346.44
- Omnipod (Device) $303.70
- MOUNJARO (Drug) $302.32
- FARXIGA (Drug) $277.61
- TRULICITY (Drug) $249.81
- Korlym (Drug) $239.50
- Tymlos (Drug) $221.92
- AFREZZA (Drug) $207.28
- Wegovy (Drug) $189.39
- BAQSIMI (Drug) $150.70
- GVOKE HYPOPEN (Drug) $148.09
- SOMAVERT (Drug) $144.86
- TZIELD (Biological) $119.93
- HUMULIN (Drug) $116.88
- SOLIQUA 100/33 (Biological) $112.03
- EVENITY (Biological) $105.93
- UNITHROID (Drug) $105.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Chesapeake
Mrs. Katia Hall, Fnp, Pmhnp, FNP, PMHNP
Family — Payments: $58,295
Family $58,295
Janelle Fitzgerald-Kratzenberg, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $48,655
Family $48,655
Jarrod Elsass, Fnp-C, FNP-C
Family — Payments: $9,366
Family $9,366
Megan Cannon, Np-C, NP-C
Family — Payments: $7,557
Family $7,557
Ms. Stephanie Hendrick, Fnp-C, FNP-C
Family — Payments: $6,546
Family $6,546
Mrs. Edith Heine, Fnp, FNP
Family — Payments: $5,951
Family $5,951